Future Healthcare of America

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20509


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


November 13, 2018

Date of Report

(Date of earliest event reported)


FUTURE HEALTHCARE OF AMERICA

(Exact name of registrant as specified in its charter)


WYOMING

000-54917

45-5547692

(State or other jurisdiction of

incorporation or organization)

Commission File Number

(I.R.S. Employer

Identification No.)


Jachthavenweg 124

1081 KJ Amsterdam

The Netherlands

(Address of principal executive offices)


011-31-68-333-1940

Registrant's telephone number


N/A

Former name or former address, if changed since last report


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))









Item 8.01.  Other Events.


Future Healthcare of America announces that it has completed its share exchange transaction with Natur Holding B.V.  See Exhibit 99.1.


Item 9.01.  Financial Statements and Exhibits.


(d)  Exhibits.


Exhibit No.

Description


99.1

Announcement of Completion of Share Exchange*



* filed herewith







SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

 

FUTURE HEALTHCARE OF AMERICA,

 

 

 

a Wyoming corporation

 

 

 

 

 

 

 

 

 

 

 

Dated:  November 15, 2018

 

By:

/S/ Ellen Berkers

 

 

 

Ellen Berkers, CEO